Navigation Links
First and Only Weaning Product Based on 100% Non-Allergenic Amino-Acids Specifically Designed for Children With Cows' Milk Protein Allergy and Multiple Food Protein Intolerance
Date:6/11/2009

ith cows' milk allergy.(4) Nutricia has a strong heritage in AAF, having developed the first one ever, Neocate, which celebrated its 25th birthday in 2008.

About Neocate Nutra

Nutricia's Neocate Nutra is the first amino acid-based weaning product for infants from 6 months and children with CMPA.

Neocate Nutra is a versatile and convenient product. When water is added to this powder-based product, a smooth, spoonable "yoghurt style" consistency is formed which can be adjusted by adding more or less water as desired. With its neutral taste, Neocate Nutra is perfect on its own or can be combined with a variety of sweet or savoury "safe" foods. Neocate is manufactured in a cows' milk protein-free plant. Neocate Nutra is suitable for infants from 6 months and young children.

National launches of Neocate Nutra will be taking place across the world during the course of 2009 and 2010.

    References

    1. Hill DJ, Firer MA, Shelton MJ., et al. Manifestations of milk allergy
       in infancy: clinical and immunologic findings. J Pediatrics 1986;
       109:270-276.
    2. Vandenplas Y. Optimising the Diagnosis and Management of Cow's Milk
       Allergy within Primary Care. European Pediatric Review, 2009; 3(1) in
       press.
    3. ESPGHAN Committee on Nutrition. Soy Protein Infant Formulae: A
       Commentary by the ESPGHAN Committee on Nutrition. JPGN 2006;
       42:352-61.
    4. Weaning, in Manual of Dietetic Practice, Second Edition, Blackwell
       Science,1994: pp264-68.
    5. Act Against Allergy Parent Survey, Oct 2008. Data on file.


'/>"/>
SOURCE Nutricia
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Mobile Massage Team to Sponsor and Exhibit at First Annual Working Wellness Expo
2. Cord Blood Registry Maintains Solid Growth in First Quarter 2009
3. PEAK Surgical Announces First Use of PEAK PlasmaBlade(TM) in Europe
4. First-degree relatives of patients with bicuspid aortic valve should be screened
5. ‘HairConfirm' Is First Drug Test of Its Kind to Report Low/Medium/High Usage; Now Available at Local Discount Drug Marts
6. First Brain Training Consumers Guide Debunks Ten Brain Health Myths and Reviews 21 Products
7. Jazz Pharmaceuticals to Present Data From First Phase III Study of Sodium Oxybate in Patients With Fibromyalgia
8. Streamline Health(R) Solutions Reports First Quarter Results
9. Nonin Medical, Inc. Announces the First Bluetooth(R) Continua(TM) Certified Product
10. Courage Center Is First in Midwest to Offer Innovative Treatment for Movement Disorders
11. Kidney Community Launches Health Care Campaign to Improve Survival Rates of First-Year Dialysis Patients in Iowa
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... Amy Norton HealthDay ... Headlines remain riveted on the three Ebola cases in Dallas. ... bigger health threat to Americans. President Barack Obama on ... to the virus, which has infected two Dallas nurses who ... month at Texas Health Presbyterian Hospital. But the U.S. ...
(Date:10/22/2014)... October 22, 2014 With the Affordable Care ... survey by the American Institutes for Research (AIR) finds that ... to use health insurance, but 42 percent say they are ... details before signing up for coverage. , The AIR survey ... 20 percent able to calculate correctly how much they owe ...
(Date:10/22/2014)... Although there are only 24 hours in a day, ... have trouble finding time within their busy schedules for exercise and ... of time to get in shape. Here are five ways you ... , Change Up Your Commute , Consider riding a bike ... exercise into your daily routine. If you must use your car ...
(Date:10/22/2014)... HealthDay Reporter , TUESDAY, Oct. 21, 2014 ... are only about half as likely as white women to ... indicates, and the racial disparity persists even when donor eggs ... white patients became pregnant after IVF, compared to about 17 ... cycles over two years to tease out the impact of ...
(Date:10/22/2014)... HealthDay Reporter , MONDAY, Oct. ... officially tightened guidelines for health workers treating Ebola patients, now ... of a respirator at all times. The U.S. Centers ... rules after two Dallas nurses contracted Ebola while caring for ... national Thomas Eric Duncan. Nina Pham is currently being treated ...
Breaking Medicine News(10 mins):Health News:Ebola Anxiety: A Bigger Threat Now Than the Virus Itself 2Health News:Ebola Anxiety: A Bigger Threat Now Than the Virus Itself 3Health News:Many Americans Fail to Ask Basic Questions Before Signing Up for Health Insurance, National Survey Finds 2Health News:Many Americans Fail to Ask Basic Questions Before Signing Up for Health Insurance, National Survey Finds 3Health News:Many Americans Fail to Ask Basic Questions Before Signing Up for Health Insurance, National Survey Finds 4Health News:HealthGuideMD Presents Ways to Improve Your Exercise and Fitness 2Health News:Black Women Fare Worse With Fertility Treatments, Study Says 2Health News:Black Women Fare Worse With Fertility Treatments, Study Says 3Health News:CDC Tightens Rules on Caring for Ebola Patients 2Health News:CDC Tightens Rules on Caring for Ebola Patients 3
... three-year contract with Mercy Regional Medical Center, the largest hospital in ... Durango, Colorado. MHS will perform this inventory for the 82-bed acute ... valuation process. www.MHSInc.com , ... Fairfield, Connecticut ...
... accurate translation and localization services for a wide range of companies ... for setting up computers to work in foreign languages such as ... ... Chicago, IL (Vocus) April 1, 2009 -- Businesses of all sizes ...
... Included in a New Law and Manages Applicants, PaperworkMADRID, April 1 ... IBM ), today announced that Junta de ... region in Spain, will be helping its citizens gain quicker access ... of a new system built around IBM ILOG JRules. The new ...
... reality television show, Little People, Big World, focuses on ... series bring achondroplasia, the most common form of dwarfism, ... published in the April 2009 issue of the ... (JAAOS), treating patients with dwarfism is an extremely complex ...
... 31 Rheumatoid arthritis (RA) is a systemic disease ... system attacks the joints through the thin layer of ... joints. The most visible symptoms of RA are swollen ... feet. It can cause fatigue, fever, loss of appetite ...
... HARBIN, China, March 31 /PRNewswire-Asia-FirstCall/ -- China Sky ... Company") (Nasdaq: CSKI ), a,leading fully ... Republic of China ("PRC"), today announced that it ... Exchange Commission,for its Annual Report on Form 10-K. ...
Cached Medicine News:Health News:Mercy Regional Medical Center Selects Management Health Solutions, Inc. for Inventory Services 2Health News:Set Up Your Computer to Work in Another Language – New Tips at Argotrans.com 2Health News:Spain's Junta De Castilla y Leon Streamlines Benefits Delivery for Dependent Care With IBM ILOG JRules 2Health News:Dealing with dwarfism 2Health News:Dealing with dwarfism 3Health News:Frost & Sullivan: Rheumatoid Arthritis Therapeutics in Malaysia 2Health News:Frost & Sullivan: Rheumatoid Arthritis Therapeutics in Malaysia 3Health News:China Sky One Medical, Inc. Files for Extension to File Form 10-K 2
(Date:10/22/2014)... 2014 Abaxis, Inc. (NasdaqGS: ABAX ... systems, today reported financial results for the second fiscal ... overview: , Revenues of $53.9 million, up 18% ... of $0.24, up 33% over last year,s comparable quarter. ... Abaxis Veterinary Reference Laboratories (AVRL) of $3.5 million, up ...
(Date:10/22/2014)... Oct. 22, 2014 WHEN: Wednesday, October 29, ... registration available at: http://bit.ly/1yStiU9 SPEAKERS: ... and Visionary Innovation Research Group Senior Research ... self-assembling materials, nanobots and flexible electronics are ... transform our lives in the coming decades. ...
(Date:10/22/2014)... Calif. , Oct. 22, 2014 /PRNewswire/ ... ), a biopharmaceutical company leading the discovery ... today announced that it has demonstrated human ... ongoing clinical study evaluating RG-101, a wholly-owned, ... treatment of hepatitis C virus infection ("HCV").  ...
Breaking Medicine Technology:Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 2Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 3Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 4Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 5Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 6Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 7Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 8Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 9Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 10Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 11Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 12Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 13Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 14Futuristic Technologies That Will Transform Our World Beyond 2030 2Futuristic Technologies That Will Transform Our World Beyond 2030 3Futuristic Technologies That Will Transform Our World Beyond 2030 4A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 2A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 3A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 4A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 5A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 6A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 7A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 8
... combination treatment for the blood cancer multiple myeloma compares favorably ... to a multi-center study led by Andrzej Jakubowiak, MD, ... myeloma program at the University of Chicago Medical Center. ... the phase I-II study on Dec. 12, 2011, at the ...
... 2011 The American Association for Homecare urges Congress ... a reform of Medicare,s pricing system that is an ... equipment and services.  "As it,s currently ... of care for seniors and people with disabilities who ...
Cached Medicine Technology:Drug Combination Highly Effective for Newly Diagnosed Myeloma Patients, Study Finds 2Drug Combination Highly Effective for Newly Diagnosed Myeloma Patients, Study Finds 3American Association for Homecare Urges Congress to Enact Market-Based Alternative to Medicare's Bidding Program for Home Medical Equipment 2American Association for Homecare Urges Congress to Enact Market-Based Alternative to Medicare's Bidding Program for Home Medical Equipment 3
Prognosis / Patient Management. HIV-1 Viral Load Assay. NucliSens HIV-1 QT covers the entire dynamic range of viral load testing from a single patient sample, without reflex testing or thermalcycli...
EIA for Donor Screening. Synthetic peptide Enzyme Immunoassay (EIA) for the detection of antibodies to Human Immunodeficiency Virus Types 1 and/or 2,(HIV-1 and HIV-2) in human serum, plasma or ca...
... The OraQuick ADVANCE ... is a single-use, qualitative ... to Human Immunodeficiency Virus ... Type 2 (HIV-2) in ...
... performance benefits of TiMAX material have been applied ... Greater strength and an ultra-low profile combine to ... the lower extremity. , ,This complete set of ... Plate , Fibula Composite Plate ...
Medicine Products: